Search filters

List of works by Shunsuke Kondo

An Oncogenic ALK Fusion and an RRAS Mutation in KRAS Mutation-Negative Pancreatic Ductal Adenocarcinoma

scientific article published on 6 February 2017

Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Patients with Esophageal Squamous Cell Carcinoma: Results from a Phase 1 Cohort in Asia

scientific article published on 11 April 2021

C-Reactive Protein Level Is an Indicator of the Aggressiveness of Advanced Pancreatic Cancer

scientific article

Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy ⬇️

scientific article published on June 25, 2012

Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma ⬇️

scientific article published on January 5, 2012

Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma ⬇️

scientific article published on 04 July 2013

Construction and Validation of a Prognostic Index for Patients With Metastatic Pancreatic Adenocarcinoma ⬇️

scientific article published on April 1, 2011

Correction to: Phase 1 dose-escalation study of a novel oral PI3K/mTOR dual inhibitor, LY3023414, in patients with cancer

scientific article published on 07 September 2020

Do all patients in the phase I oncology trials need to be hospitalized? Domestic but outstanding issues for globalization of drug development in Japan

scientific article

Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization ⬇️

scientific article published on June 23, 2013

Evaluating Clinical Genome Sequence Analysis by Watson for Genomics

scientific article published on 09 November 2018

First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors

scientific article published on 24 January 2019

First-in-human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors

scientific article published on 01 February 2020

Gemcitabine-induced Pleuropericardial Effusion in a Patient with Pancreatic Cancer ⬇️

scientific article published on July 10, 2012

Germline mutations in cancer-predisposition genes in patients with biliary tract cancer

scientific article published on 15 October 2019

Global trends in the distribution of cancer types among patients in oncology phase I trials, 1991-2015

scientific article published on 07 August 2018

Hepatitis B Virus Reactivation during Treatment with Multi-Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma ⬇️

scientific article published on September 28, 2012

Impact of Hepatitis Virus on the Feasibility and Efficacy of Anticancer Agents in Patients With Hepatocellular Carcinoma in Phase I Clinical Trials

scientific article published on 18 April 2019

Impact of the Duration of Diabetes Mellitus on the Outcome of Metastatic Pancreatic Cancer Treated with Gemcitabine: A Retrospective Study

scientific article published on 07 June 2019

Impact of the Integrin Signaling Adaptor Protein NEDD9 on Prognosis and Metastatic Behavior of Human Lung Cancer ⬇️

scientific article published on October 4, 2012

Improved survival among patients enrolled in oncology phase 1 trials in recent decades

scientific article published on 19 November 2019

Lipid profiling of pre-treatment plasma reveals biomarker candidates associated with response rates and hand-foot skin reactions in sorafenib-treated patients

scientific article published on 30 July 2018

Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase 1 study

scientific article published on 17 May 2019

Novel endoscopic technique for tri-segment drainage in patients with unresectable hilar malignant biliary strictures (with video)

scientific article published on 10 March 2020

Pancreatic neuroendocrine tumors: A single-center 20-year experience with 100 patients

scientific article

Phase 1 Trial of Wilms Tumor 1 (WT1) Peptide Vaccine and Gemcitabine Combination Therapy in Patients With Advanced Pancreatic or Biliary Tract Cancer ⬇️

scientific article published on January 1, 2011

Phase 1 dose-escalation study of a novel oral PI3K/mTOR dual inhibitor, LY3023414, in patients with cancer

scientific article published on 23 June 2020

Phase I study of the indoleamine 2,3-dioxygenase 1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with the PD-L1 inhibitor atezolizumab in Japanese patients with advanced solid tumours

scientific article published on 24 May 2019

Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients ⬇️

scientific article published on November 26, 2011

Prognostic Factors for Survival in Patients with Advanced Intrahepatic Cholangiocarcinoma Treated with Gemcitabine plus Cisplatin as First-Line Treatment

scientific article

Quality evaluation of investigator-initiated trials using post-approval cancer drugs in Japan.

scientific article

Treatment outcome for systemic chemotherapy for recurrent pancreatic cancer after postoperative adjuvant chemotherapy ⬇️

scientific article published on July 24, 2012

Twenty-six cases of advanced ampullary adenocarcinoma treated with systemic chemotherapy

scientific article published on 30 January 2014

Utility of Assessing the Number of Mutated KRAS, CDKN2A, TP53, and SMAD4 Genes Using a Targeted Deep Sequencing Assay as a Prognostic Biomarker for Pancreatic Cancer

scientific article

Paulina is supported by:

About Paulina

Help